Basic Science: Visual Attention in Healthy ParticipantsNCT06175312
Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Expt 1.1)
A study testing Stimulus properties: salience-defining feature and Stimulus properties: magnitude of salience in people with Basic Science: Visual Attention in Healthy Participants and Basic Science: Neural Representations of Location, run by University of California, Santa Barbara at 1 site in United States.
Trial summary
How does one know what to look at in a scene? Imagine a "Where's Waldo" game - it's challenging to find Waldo because there are many 'salient' locations in the picture, each vying for one's attention. Read more about this study
- Who is it for?
- Ages 18 to 55 yearsHealthy volunteers can take part
- Conditions the study is for
- Basic Science: Visual Attention in Healthy Participants, Basic Science: Neural Representations of Location, Attention
- What is being tested?
- Stimulus properties: salience-defining feature and Stimulus properties: magnitude of salience
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteUnited States
- Study dates
- 25 Apr 2024to 31 Jan 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- between 18 and 55 years of age
- normal or corrected-to-normal vision
Who cannot join
- neurological disease based on self-report
- implanted medical devices (e.g., cardiac pacemaker; metallic aneurism clip)
- non-removable metallic piercings
- metal fragments in the body (e.g., from welding)
- pregnant and have a chance of being pregnant (if female)
- history of claustrophobia
- history of hearing loss/damage
Trial locations and contacts
1 site in 1 country.
United States1 site
University of California, Santa Barbara
Santa Barbara, California, 93117
About this study
Official title: Probing the Role of Feature Dimension Maps in Visual Cognition: Expt 1.1
How does one know what to look at in a scene? Imagine a "Where's Waldo" game - it's challenging to find Waldo because there are many 'salient' locations in the picture, each vying for one's attention. One can only attend to a small location on the picture at a given moment, so to find Waldo, one needs to direct their attention to different locations. One prominent theory about how one accomplishes this claims that important locations are identified based on distinct feature types (for example, motion or color), with locations most unique compared to the background most likely to be attended. An important component of this theory is that individual feature dimensions (again, color or motion) are computed within their own 'feature maps', which are thought to be implemented in specific brain regions. However, whether and how specific brain regions contribute to these feature maps remains unknown.
The goal of this study is to determine how brain regions that respond strongly to different feature types (color and motion) and which encode spatial locations of visual stimuli extract 'feature dimension maps' based on stimulus properties, including feature contrast. The investigators hypothesize that feature-selective brain regions act as neural feature dimension maps, and thus encode representations of salient location(s) based on their preferred feature dimension. The investigators will scan healthy human participants using functional MRI (fMRI) in a repeated-measures design while they view visual stimuli made salient based on different combinations of feature dimensions. The investigators will employ state-of-the-art multivariate analysis techniques that allow them to reconstruct an 'image' of the stimulus representation encoded by each brain region to dissect how neural tissue identifies salient locations. Each participant will perform a challenging task at the center of the screen to ensure they keep their eyes still and ignore the stimuli presented in the periphery, which are used to gauge how the visual system automatically extracts important locations without confounding factors like eye movements. Across trials and experiments the investigators will manipulate 1) the 'strength' of the salient locations based on how different the salient stimulus is compared to the background, 2) the number of salient locations, and 3) the feature value(s) used to make each location salient. Altogether, these manipulations will help the investigators fully understand these critical salience computations in the healthy human visual system.
Read the detailed description
In this experiment, participants will engage in all task conditions in a repeated-measures design. Participants are not randomly assigned to groups, as all participants will experience the same set of experimental manipulations. In this experiment, participants will engage in a series of challenging visual attention tasks while their eye position is tracked during fMRI scanning.
In all tasks, participants will perform challenging discrimination judgments based on a stimulus presented at the fixation point (discriminate the aspect ratio of a + target - wide or tall?). Behavioral responses will be recorded with a button press, which participants will make using a fMRI-compatible button box held in their right hand.
In this Experiment, the investigators will manipulate aspects of the stimulus display while holding the behavioral task constant. These manipulations will allow the investigators to test the role of feature-selective retinotopic regions of interest (ROIs) in automatically extracting salient information from the environment to guide visual attention.
In this Experiment (Experiment 1.1), the investigators will test the effect of changing the salience-defining feature of a visual stimulus display on stimulus representations reconstructed from fMRI activation patterns in feature-selective retinotopic ROIs. Participants will continuously perform the challenging fixation discrimination task while occasional salient stimuli appear. Stimuli will consist of flickering checkerboards, static colored dot fields with localized salient patches of differently-colored dots, and moving grayscale dot fields with localized salient patches of dots moving in a different direction. Single neurons in macaque visual cortex have been shown to respond to salient stimuli, and so the investigators expect to see, based on these previous studies, a substantial representation of the salient stimulus location in response patterns measured from feature-selective brain regions.
Participants will also be scanned for an anatomical \& retinotopic mapping session, which will allow the investigators to identify brain regions for further analysis using well-established and standardized procedures.
STATISTICAL DESIGN \& POWER
The fMRI studies described in this study record employ an inverted encoding model (IEM) for spatial position to quantify stimulus representations in reconstructed spatial maps of the visual field based on activation patterns measured in retinotopic feature-selective ROIs. The investigators rigorously identify ROIs using independent retinotopic mapping and localizer techniques, and use a 'mapping' task to estimate a 'fixed' encoding model for use across all conditions in each Experiment reported. These design decisions ensure that the investigators can maximize their ability to detect effects of their manipulations of interest within individual participants and brain regions and maximize the statistical power. The investigators use a compromise between deep imaging of several experimental and stimulus conditions within individual participants and aggregation of data across a moderate sample of these deeply-imaged participants (n = 10; see below). This allows the investigators to attain high-quality, reproducible estimates of model-based stimulus representations across task and stimulus manipulations within individual participants and conduct statistical inference on these measurements across the study sample.
fMRI analyses will be conducted within each participant's individual brain, and voxels are assigned 'region' labels according to independent criteria (functional retinotopic mapping). Accordingly, there are no comparisons that require precise alignment of brain tissue between participants, and no generation of group-averaged 'maps' of brain activation. As such, concerns about reproducibility of brain maps and associated statistical power concerns are irrelevant to this study design.
The statistical design of the study is a repeated-measures design, whereby each participant is exposed to all manipulations in the study. The order of manipulations each participant experiences is randomized across participants. The investigators will employ nonparametric randomization tests for all statistical comparisons whereby they will conduct hypothesis testing (e.g., repeated-measures analysis of variance) using 'shuffled' data (misaligned condition labels relative to measured map activation on each trial) to generate a null distribution of test statistics under the null hypothesis of no effect of their independent variable(s). Once this procedure is repeated extensively (1,000 times) per test, the p-value can be estimated by comparing the test statistic computed using intact labels to this null distribution, and corrected for multiple comparisons as appropriate (e.g., via false discovery rate). Using permutation procedures to generate a null distribution minimizes reliance on parametric assumptions.
Additionally, the experiments within the study are designed such that sufficient data will be acquired that data from each individual participant can be used to test the effects of interest. Accordingly, each participant can be considered independent 'replication' of each other participant. Previous studies adopting a similar methodology whereby IEM-based reconstructions of visual stimuli are compared between conditions have employed relatively small sample sizes (n = 8; n = 8; n = 7). Other studies using population receptive field models or location-specific functional localizer, which are in principle very similar to the approach employed here, have used smaller sample sizes (e.g., n = 6).
Sample size \& statistical power:
In this study, the investigators will acquire an intermediate sample size with extensive data per task condition (n = 10; 2 experimental fMRI sessions, each 1.5-2 hrs, for each participant; along with a 2-hr anatomical imaging and retinotopic mapping fMRI session). Of particular interest, one study used n = 6 participants to establish with a large effect size dz = 3.52 that V1 voxels tuned to a stimulus location where a salient stimulus was defined by feature contrast respond more strongly than when feature contrast is absent. In another study, similar effect sizes were reported by this group in a color-selective ROI known as hV4 (n = 6; dz = 1.06 and 1.80 for orientation- and motion-based contrast, respectively).
Accordingly, assuming a conservative effect size of 0.90 (based on those reported previously), the investigators expect a sample size of n = 10 will allow the study to be well-powered (80%, α = 0.05) to detect a similar change in this Experiment (Experiment 1.1), which is most analogous to this study (one-tailed paired T-test).
Additionally, the investigators used their pilot data (n = 3) to measure the effect size for the critical comparison between salience-related modulations between feature-selective regions to be dz = 3.10 for the salience-defining feature. These values are commensurate with those cited above, and further support the selection of sample size. If analyses of data acquired during further pilot testing \& experiment refinement suggest smaller effect sizes, the investigators will refine the power analyses and adjust the projected enrollment accordingly to ensure robust and reproducible results. Note that this power analysis relies on parametric assumptions which will not be required for the proposed analyses, which invoke randomization methods to compute empirical null distributions.
- Conditions
- Basic Science: Visual Attention in Healthy Participants, Basic Science: Neural Representations of Location, Attention
- Being tested
- Stimulus properties: salience-defining feature, Stimulus properties: magnitude of salience
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Stimulus properties: salience-defining featureOther
The feature used to define a salient location will be varied across trials (checkerboard contrast; motion direction; color hue)
Stimulus properties: magnitude of salienceOther
The magnitude of the salient location will be varied across trials independently from salience-defining feature (based on feature contrast)
| Study group | Role | What they receive |
|---|---|---|
| Manipulations of graded feature salience (Expt 1.1) | Experimental | Participants will view stimuli made salient based on feature contrast in one feature dimensions (color or motion direction; or checkerboard luminance contrast). The degree to which a location is salient will be manipulated based on the feature contrast across multiple values Receives: Other: Stimulus properties: salience-defining feature; Other: Stimulus properties: magnitude of salience |
What is being measured
The primary outcome is the main question the study is designed to answer.
Blood Oxygenation Level Dependent (BOLD) fMRI signal
The investigators will use BOLD activation patterns measured from each retinotopic ROI to fit quantitative models of spatial encoding. These models will be used to reconstruct stimulus representations on experimental trials to quantify how stimulus representations are encoded in each brain region studied, and how these representations change across experimental manipulations. These measurements will be used to test the impact of stimulus manipulations on stimulus representations in different brain regions.
Measured: Through study completion, an average of two weeks
Gaze position
The investigators will use the measured gaze position in (x,y) coordinates to verify stable fixation throughout the experiment. Trials with poor fixation performance may be excluded from further analyses.
Measured: Through study completion, an average of two weeks
Behavioral response (button press)
On all trials participants will be instructed to attend carefully to the fixation point and report the shape of a target '+' (wide or tall) by pressing one of two buttons held in their hand inside the scanner. The left button will indicate wide; the right button will indicate tall. The investigators will ensure participants are performing the task as instructed by assessing the accuracy of their behavioral responses.
Measured: Through study completion, an average of two weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Dec 2023
- Study start25 Apr 2024
- Primary completion31 Jan 2025
- Study completion31 Jan 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (17)Papers the sponsor has linked to this study.
- Other trials for Basic Science: Visual Attention in Healthy ParticipantsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- This is a basic science study in which all participants will participate in all task conditions within each experiment (repeated-measures design).
- Masking
- None (open label)
- Enrolment
- 10 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of California, Santa Barbara
- Sponsor type
- University, hospital or other
- Collaborators
- National Eye Institute (NEI)
- Responsible party
- Sponsor
- Investigators
- Tommy C Sprague, Principal investigator, University of California, Santa Barbara
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06175312
- Sponsor's protocol ID
- 5-23-0569: 1.1
- Other IDs
- R01EY035300
- Status last verified
- May 2025
- First submitted
- 5 Dec 2023
- Last updated
- 23 May 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Processed fMRI and raw behavioral data will be shared with researchers immediately upon publication
Publications
Mackey WE, Winawer J, Curtis CE. Visual field map clusters in human frontoparietal cortex. Elife. 2017 Jun 19;6:e22974. doi: 10.7554/eLife.22974.
PubMed 28628004Hallenbeck GE, Sprague TC, Rahmati M, Sreenivasan KK, Curtis CE. Working memory representations in visual cortex mediate distraction effects. Nat Commun. 2021 Aug 5;12(1):4714. doi: 10.1038/s41467-021-24973-1.
PubMed 34354071Sprague TC, Itthipuripat S, Vo VA, Serences JT. Dissociable signatures of visual salience and behavioral relevance across attentional priority maps in human cortex. J Neurophysiol. 2018 Jun 1;119(6):2153-2165. doi: 10.1152/jn.00059.2018. Epub 2018 Feb 28.
PubMed 29488841Sprague TC, Adam KCS, Foster JJ, Rahmati M, Sutterer DW, Vo VA. Inverted Encoding Models Assay Population-Level Stimulus Representations, Not Single-Unit Neural Tuning. eNeuro. 2018 Jun 5;5(3):ENEURO.0098-18.2018. doi: 10.1523/ENEURO.0098-18.2018. eCollection 2018 May-Jun. No abstract available.
PubMed 29876523Sprague TC, Boynton GM, Serences JT. The Importance of Considering Model Choices When Interpreting Results in Computational Neuroimaging. eNeuro. 2019 Dec 20;6(6):ENEURO.0196-19.2019. doi: 10.1523/ENEURO.0196-19.2019. Print 2019 Nov/Dec.
PubMed 31772033Laumann TO, Gordon EM, Adeyemo B, Snyder AZ, Joo SJ, Chen MY, Gilmore AW, McDermott KB, Nelson SM, Dosenbach NU, Schlaggar BL, Mumford JA, Poldrack RA, Petersen SE. Functional System and Areal Organization of a Highly Sampled Individual Human Brain. Neuron. 2015 Aug 5;87(3):657-70. doi: 10.1016/j.neuron.2015.06.037. Epub 2015 Jul 23.
PubMed 26212711Allen EJ, St-Yves G, Wu Y, Breedlove JL, Prince JS, Dowdle LT, Nau M, Caron B, Pestilli F, Charest I, Hutchinson JB, Naselaris T, Kay K. A massive 7T fMRI dataset to bridge cognitive neuroscience and artificial intelligence. Nat Neurosci. 2022 Jan;25(1):116-126. doi: 10.1038/s41593-021-00962-x. Epub 2021 Dec 16.
PubMed 34916659Fedorenko E. The early origins and the growing popularity of the individual-subject analytic approach in human neuroscience. Current Opinion in Behavioral Sciences. 2021; 40:105-112.
Naselaris T, Allen E, Kay K. Extensive sampling for complete models of individual brains. Current Opinion in Behavioral Sciences. 2021; 40:45-51.
Poldrack RA. Diving into the deep end: a personal reflection on the MyConnectome study. Current Opinion in Behavioral Sciences. 2021; 40:1-4.
Pritschet L, Taylor CM, Santander T, Jacobs EG. Applying dense-sampling methods to reveal dynamic endocrine modulation of the nervous system. Curr Opin Behav Sci. 2021 Aug;40:72-78. doi: 10.1016/j.cobeha.2021.01.012. Epub 2021 Feb 25.
PubMed 35369044Gratton C, Nelson SM, Gordon EM. Brain-behavior correlations: Two paths toward reliability. Neuron. 2022 May 4;110(9):1446-1449. doi: 10.1016/j.neuron.2022.04.018.
PubMed 35512638Smith PL, Little DR. Small is beautiful: In defense of the small-N design. Psychon Bull Rev. 2018 Dec;25(6):2083-2101. doi: 10.3758/s13423-018-1451-8.
PubMed 29557067Sprague TC, Serences JT. Attention modulates spatial priority maps in the human occipital, parietal and frontal cortices. Nat Neurosci. 2013 Dec;16(12):1879-87. doi: 10.1038/nn.3574. Epub 2013 Nov 10.
PubMed 24212672Itthipuripat S, Vo VA, Sprague TC, Serences JT. Value-driven attentional capture enhances distractor representations in early visual cortex. PLoS Biol. 2019 Aug 9;17(8):e3000186. doi: 10.1371/journal.pbio.3000186. eCollection 2019 Aug.
PubMed 31398186
Study at a glance
From the registry record, last updated by the sponsor on 23 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Probing the Role of Feature Dimension Maps in Visual Cognition: Expt 1.1
- ClinicalTrials.gov ID
- NCT06175312
- Acronym / sponsor ID
- 5-23-0569: 1.1
- Conditions
- Basic Science: Visual Attention in Healthy Participants, Basic Science: Neural Representations of Location, Attention
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 10 participants (actual)
- Lead sponsor
- University of California, Santa BarbaraUniversity, hospital or other
- Collaborators
- National Eye Institute (NEI)
- Study start
- 25 Apr 2024 (actual)
- Primary completion
- 31 Jan 2025 (actual)
- Study completion
- 31 Jan 2025 (actual)
- First posted
- 18 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
How does one know what to look at in a scene? Imagine a "Where's Waldo" game - it's challenging to find Waldo because there are many 'salient' locations in the picture, each vying for one's attention. One can only attend to a small location on the picture at a given moment, so to find Waldo, one needs to direct their attention to different locations. One prominent theory about how one accomplishes this claims that important locations are identified based on distinct feature types (for example, motion or color), with locations most unique compared to the background most likely to be attended. An important component of this theory is that individual feature dimensions (again, color or motion) are computed within their own 'feature maps', which are thought to be implemented in specific brain regions. However, whether and how specific brain regions contribute to these feature maps remains unknown.
The goal of this study is to determine how brain regions that respond strongly to different feature types (color and motion) and which encode spatial locations of visual stimuli extract 'feature dimension maps' based on stimulus properties, including feature contrast. The investigators hypothesize that feature-selective brain regions act as neural feature dimension maps, and thus encode representations of salient location(s) based on their preferred feature dimension. The investigators will scan healthy human participants using functional MRI (fMRI) in a repeated-measures design while they view visual stimuli made salient based on different combinations of feature dimensions. The investigators will employ state-of-the-art multivariate analysis techniques that allow them to reconstruct an 'image' of the stimulus representation encoded by each brain region to dissect how neural tissue identifies salient locations. Each participant will perform a challenging task at the center of the screen to ensure they keep their eyes still and ignore the stimuli presented in the periphery, which are used to gauge how the visual system automatically extracts important locations without confounding factors like eye movements. Across trials and experiments the investigators will manipulate 1) the 'strength' of the salient locations based on how different the salient stimulus is compared to the background, 2) the number of salient locations, and 3) the feature value(s) used to make each location salient. Altogether, these manipulations will help the investigators fully understand these critical salience computations in the healthy human visual system.
Detailed description
In this experiment, participants will engage in all task conditions in a repeated-measures design. Participants are not randomly assigned to groups, as all participants will experience the same set of experimental manipulations. In this experiment, participants will engage in a series of challenging visual attention tasks while their eye position is tracked during fMRI scanning.
In all tasks, participants will perform challenging discrimination judgments based on a stimulus presented at the fixation point (discriminate the aspect ratio of a + target - wide or tall?). Behavioral responses will be recorded with a button press, which participants will make using a fMRI-compatible button box held in their right hand.
In this Experiment, the investigators will manipulate aspects of the stimulus display while holding the behavioral task constant. These manipulations will allow the investigators to test the role of feature-selective retinotopic regions of interest (ROIs) in automatically extracting salient information from the environment to guide visual attention.
In this Experiment (Experiment 1.1), the investigators will test the effect of changing the salience-defining feature of a visual stimulus display on stimulus representations reconstructed from fMRI activation patterns in feature-selective retinotopic ROIs. Participants will continuously perform the challenging fixation discrimination task while occasional salient stimuli appear. Stimuli will consist of flickering checkerboards, static colored dot fields with localized salient patches of differently-colored dots, and moving grayscale dot fields with localized salient patches of dots moving in a different direction. Single neurons in macaque visual cortex have been shown to respond to salient stimuli, and so the investigators expect to see, based on these previous studies, a substantial representation of the salient stimulus location in response patterns measured from feature-selective brain regions.
Participants will also be scanned for an anatomical \& retinotopic mapping session, which will allow the investigators to identify brain regions for further analysis using well-established and standardized procedures.
STATISTICAL DESIGN \& POWER
The fMRI studies described in this study record employ an inverted encoding model (IEM) for spatial position to quantify stimulus representations in reconstructed spatial maps of the visual field based on activation patterns measured in retinotopic feature-selective ROIs. The investigators rigorously identify ROIs using independent retinotopic mapping and localizer techniques, and use a 'mapping' task to estimate a 'fixed' encoding model for use across all conditions in each Experiment reported. These design decisions ensure that the investigators can maximize their ability to detect effects of their manipulations of interest within individual participants and brain regions and maximize the statistical power. The investigators use a compromise between deep imaging of several experimental and stimulus conditions within individual participants and aggregation of data across a moderate sample of these deeply-imaged participants (n = 10; see below). This allows the investigators to attain high-quality, reproducible estimates of model-based stimulus representations across task and stimulus manipulations within individual participants and conduct statistical inference on these measurements across the study sample.
fMRI analyses will be conducted within each participant's individual brain, and voxels are assigned 'region' labels according to independent criteria (functional retinotopic mapping). Accordingly, there are no comparisons that require precise alignment of brain tissue between participants, and no generation of group-averaged 'maps' of brain activation. As such, concerns about reproducibility of brain maps and associated statistical power concerns are irrelevant to this study design.
The statistical design of the study is a repeated-measures design, whereby each participant is exposed to all manipulations in the study. The order of manipulations each participant experiences is randomized across participants. The investigators will employ nonparametric randomization tests for all statistical comparisons whereby they will conduct hypothesis testing (e.g., repeated-measures analysis of variance) using 'shuffled' data (misaligned condition labels relative to measured map activation on each trial) to generate a null distribution of test statistics under the null hypothesis of no effect of their independent variable(s). Once this procedure is repeated extensively (1,000 times) per test, the p-value can be estimated by comparing the test statistic computed using intact labels to this null distribution, and corrected for multiple comparisons as appropriate (e.g., via false discovery rate). Using permutation procedures to generate a null distribution minimizes reliance on parametric assumptions.
Additionally, the experiments within the study are designed such that sufficient data will be acquired that data from each individual participant can be used to test the effects of interest. Accordingly, each participant can be considered independent 'replication' of each other participant. Previous studies adopting a similar methodology whereby IEM-based reconstructions of visual stimuli are compared between conditions have employed relatively small sample sizes (n = 8; n = 8; n = 7). Other studies using population receptive field models or location-specific functional localizer, which are in principle very similar to the approach employed here, have used smaller sample sizes (e.g., n = 6).
Sample size \& statistical power:
In this study, the investigators will acquire an intermediate sample size with extensive data per task condition (n = 10; 2 experimental fMRI sessions, each 1.5-2 hrs, for each participant; along with a 2-hr anatomical imaging and retinotopic mapping fMRI session). Of particular interest, one study used n = 6 participants to establish with a large effect size dz = 3.52 that V1 voxels tuned to a stimulus location where a salient stimulus was defined by feature contrast respond more strongly than when feature contrast is absent. In another study, similar effect sizes were reported by this group in a color-selective ROI known as hV4 (n = 6; dz = 1.06 and 1.80 for orientation- and motion-based contrast, respectively).
Accordingly, assuming a conservative effect size of 0.90 (based on those reported previously), the investigators expect a sample size of n = 10 will allow the study to be well-powered (80%, α = 0.05) to detect a similar change in this Experiment (Experiment 1.1), which is most analogous to this study (one-tailed paired T-test).
Additionally, the investigators used their pilot data (n = 3) to measure the effect size for the critical comparison between salience-related modulations between feature-selective regions to be dz = 3.10 for the salience-defining feature. These values are commensurate with those cited above, and further support the selection of sample size. If analyses of data acquired during further pilot testing \& experiment refinement suggest smaller effect sizes, the investigators will refine the power analyses and adjust the projected enrollment accordingly to ensure robust and reproducible results. Note that this power analysis relies on parametric assumptions which will not be required for the proposed analyses, which invoke randomization methods to compute empirical null distributions.
Study design
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- This is a basic science study in which all participants will participate in all task conditions within each experiment (repeated-measures design).
| Arm | Type | Receives |
|---|---|---|
| Manipulations of graded feature salience (Expt 1.1) | Experimental | Other: Stimulus properties: salience-defining feature, Other: Stimulus properties: magnitude of salienceParticipants will view stimuli made salient based on feature contrast in one feature dimensions (color or motion direction; or checkerboard luminance contrast). The degree to which a location is salient will be manipulated based on the feature contrast across multiple values |
Who may qualify
- Ages
- 18 to 55 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- between 18 and 55 years of age
- normal or corrected-to-normal vision
Key exclusion criteria (7 listed)
- neurological disease based on self-report
- implanted medical devices (e.g., cardiac pacemaker; metallic aneurism clip)
- non-removable metallic piercings
- metal fragments in the body (e.g., from welding)
- pregnant and have a chance of being pregnant (if female)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Stimulus properties: salience-defining featureThe feature used to define a salient location will be varied across trials (checkerboard contrast; motion direction; color hue) | Other | Manipulations of graded feature salience (Expt 1.1) |
| Stimulus properties: magnitude of salienceThe magnitude of the salient location will be varied across trials independently from salience-defining feature (based on feature contrast) | Other | Manipulations of graded feature salience (Expt 1.1) |
Primary outcome
Blood Oxygenation Level Dependent (BOLD) fMRI signal
Time frame: Through study completion, an average of two weeks
The investigators will use BOLD activation patterns measured from each retinotopic ROI to fit quantitative models of spatial encoding. These models will be used to reconstruct stimulus representations on experimental trials to quantify how stimulus representations are encoded in each brain region studied, and how these representations change across experimental manipulations. These measurements will be used to test the impact of stimulus manipulations on stimulus representations in different brain regions.
Gaze position
Time frame: Through study completion, an average of two weeks
The investigators will use the measured gaze position in (x,y) coordinates to verify stable fixation throughout the experiment. Trials with poor fixation performance may be excluded from further analyses.
Behavioral response (button press)
Time frame: Through study completion, an average of two weeks
On all trials participants will be instructed to attend carefully to the fixation point and report the shape of a target '+' (wide or tall) by pressing one of two buttons held in their hand inside the scanner. The left button will indicate wide; the right button will indicate tall. The investigators will ensure participants are performing the task as instructed by assessing the accuracy of their behavioral responses.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 May 2025.
- Background: PubMed 28628004Mackey WE, Winawer J, Curtis CE. Visual field map clusters in human frontoparietal cortex. Elife. 2017 Jun 19;6:e22974. doi: 10.7554/eLife.22974.
- Background: PubMed 34354071Hallenbeck GE, Sprague TC, Rahmati M, Sreenivasan KK, Curtis CE. Working memory representations in visual cortex mediate distraction effects. Nat Commun. 2021 Aug 5;12(1):4714. doi: 10.1038/s41467-021-24973-1.
- Background: PubMed 29488841Sprague TC, Itthipuripat S, Vo VA, Serences JT. Dissociable signatures of visual salience and behavioral relevance across attentional priority maps in human cortex. J Neurophysiol. 2018 Jun 1;119(6):2153-2165. doi: 10.1152/jn.00059.2018. Epub 2018 Feb 28.
- Background: PubMed 29876523Sprague TC, Adam KCS, Foster JJ, Rahmati M, Sutterer DW, Vo VA. Inverted Encoding Models Assay Population-Level Stimulus Representations, Not Single-Unit Neural Tuning. eNeuro. 2018 Jun 5;5(3):ENEURO.0098-18.2018. doi: 10.1523/ENEURO.0098-18.2018. eCollection 2018 May-Jun. No abstract available.
- Background: PubMed 31772033Sprague TC, Boynton GM, Serences JT. The Importance of Considering Model Choices When Interpreting Results in Computational Neuroimaging. eNeuro. 2019 Dec 20;6(6):ENEURO.0196-19.2019. doi: 10.1523/ENEURO.0196-19.2019. Print 2019 Nov/Dec.
- Background: PubMed 26212711Laumann TO, Gordon EM, Adeyemo B, Snyder AZ, Joo SJ, Chen MY, Gilmore AW, McDermott KB, Nelson SM, Dosenbach NU, Schlaggar BL, Mumford JA, Poldrack RA, Petersen SE. Functional System and Areal Organization of a Highly Sampled Individual Human Brain. Neuron. 2015 Aug 5;87(3):657-70. doi: 10.1016/j.neuron.2015.06.037. Epub 2015 Jul 23.
- Background: PubMed 34916659Allen EJ, St-Yves G, Wu Y, Breedlove JL, Prince JS, Dowdle LT, Nau M, Caron B, Pestilli F, Charest I, Hutchinson JB, Naselaris T, Kay K. A massive 7T fMRI dataset to bridge cognitive neuroscience and artificial intelligence. Nat Neurosci. 2022 Jan;25(1):116-126. doi: 10.1038/s41593-021-00962-x. Epub 2021 Dec 16.
- BackgroundFedorenko E. The early origins and the growing popularity of the individual-subject analytic approach in human neuroscience. Current Opinion in Behavioral Sciences. 2021; 40:105-112.
- BackgroundNaselaris T, Allen E, Kay K. Extensive sampling for complete models of individual brains. Current Opinion in Behavioral Sciences. 2021; 40:45-51.
- BackgroundPoldrack RA. Diving into the deep end: a personal reflection on the MyConnectome study. Current Opinion in Behavioral Sciences. 2021; 40:1-4.
- Background: PubMed 35369044Pritschet L, Taylor CM, Santander T, Jacobs EG. Applying dense-sampling methods to reveal dynamic endocrine modulation of the nervous system. Curr Opin Behav Sci. 2021 Aug;40:72-78. doi: 10.1016/j.cobeha.2021.01.012. Epub 2021 Feb 25.
- Background: PubMed 35512638Gratton C, Nelson SM, Gordon EM. Brain-behavior correlations: Two paths toward reliability. Neuron. 2022 May 4;110(9):1446-1449. doi: 10.1016/j.neuron.2022.04.018.
- Individual participant dataSharing planned: Yes. Processed fMRI and raw behavioral data will be shared with researchers immediately upon publication
Related trials for Basic Science: Visual Attention in Healthy Participants
Enrolling by invitation
Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Task Demands and Spatial Attention (Expt 2.2)
Basic Science: Visual Attention in Healthy Participants, Basic Science: Neural Representations of Location
Enrolling by invitation
Probing the Role of Feature Dimension Maps in Visual Cognition: Manipulations of Relevant Locations on Salience Processing? (Expt 3.1 Pilot)
Basic Science: Visual Attention in Healthy Participants, Attention
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Tommy C Sprague principal investigator
University of California, Santa Barbara
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Stimulus properties: salience-defining feature and Stimulus properties: magnitude of salience in people with Basic Science: Visual Attention in Healthy Participants and Basic Science: Neural Representations of Location, run by University of California, Santa Barbara at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Blood Oxygenation Level Dependent (BOLD) fMRI signal (time frame: Through study completion, an average of two weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06175312, which also lists 17 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2025.